InspireMD, Inc. (NSPR)


NYSE MKT - NYSE MKT Real Time Price. Currency in USD
0.10+0.00 (+1.88%)
As of 10:00 AM EDT. Market open.
People also watch:
AMDAETRMSKLNLPTNIMNP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.10
Prev Close0.10
Bid0.10 x 1900
Ask0.10 x 6000
Day's Range0.10 - 0.10
52wk Range0.09 - 2.12
1y Target EstN/A
Market Cap3.14M
P/E Ratio (ttm)-0.08
Beta0.21
Volume97,296
Avg Vol (3m)1,708,160
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Marketwired20 days ago

    InspireMD Appoints Thomas Kester to Board of Directors

    InspireMD, Inc. , a leader in embolic prevention systems , neurovascular devices and thrombus management technologies, today announced the appointment of Thomas Kester to the Company's Board of Directors ...

  • InspireMD, Inc. :NSPR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube2 months ago

    InspireMD, Inc. :NSPR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis InspireMD, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of InspireMD, Inc. – Stryker Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson and Spectranetics Corporation (SYK-US, EW-US, BSX-US, ABT-US, JNJ-US and SPNC-US) that ... Read more (Read more...)

  • Marketwired2 months ago

    InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016

    InspireMD, Inc. , a leader in embolic prevention systems , neurovascular devices and thrombus management technologies, today announced financial and operating results for the second quarter ended June ...